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The chief biological risks associated with
exposure to chemical mutagens are likely
to be the induction of mutations in germ
cells and of cancers in somatic cells. This
workshop has been concerned primarily
with developing test systems for assessing
the germinal risks. Since the induction of
cancers may represent a burden to society
and the individual which is comparable to,
and possibly much greater on a short-term
basis, than the induction of new hereditary
defects, it is important to supplement gene-
tic test systems with somatic ones. More-
over, there would appear to be an increas-
ing need to devise somatic test systems
which would have the capability of early
detection of a sudden rise in cancer risks in
human populations.
Since for most cancers in adults the in-
terval between induction and onset of symp-
toms is probably many years it would clear-
ly be inefficient to use such cancers in an
early-warning system. A notable exception,
however, is leukemia, the acute form of
which may have a minimal latent period
of no longer than two years, judging by a
follow-up study (1) of adults exposed to
ionizing radiation, and it is possible that
the minimal latent period is as short as one
or two months. If the association of an
elevated risk of childhood leukemia with
prenatal irradiation (2,3) is a causal one,
then the minimal latent period in this case
*Division of Biology, California Institute of Tech-
nology, Pasadena, California 91109.
can be shown to be no longer than three
years, in the sense that the elevated risk
has already begun to be manifested in two-
year old children (4-6).
I would like to propose that serious con-
sideration be given to initiating a program
of prompt monitoring and analysis of leu-
kemia deaths on a national scale. I will out-
line only a few of the reasons for thinking
that such a program is feasible and poten-
tially able to provide early detection of any
increase in somatic risks that might result
from environmental agents. At the outset,
it should be emphasized that the proposed
program will be quite restricted in the type
of somatic risk it can hope to detect. Thus,
a chemical agent that is able to reach and
induce cancers in such sites as the skin,
lungs, or lining of the digestive tract may
fail for one reason or another to reach
either the bone marrow or the germ cells
and therefore be neither leukemogenic nor
mnutagenic. On the other hand, it seems like-
ly that chemical agents which are able to
reach the bone marrow and to induce leu-
kemia will tend to reach all organs and there-
fore be general carcinogens and often muta-
gens as well.
The principal reasons for singling out leu-
kemia as the disease of choice for a pro-
gram of early risk detection are: (a) the
acute form of the disease may, as already
noted, have an extremely short latent per-
iod; (b) leukemia tends to be more accur-
ately diagnosed and more accurately re-
ported on death records than are other can-
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rates in the U.S. white population appear to
have largely stabilized, judging by the ex-
perience in the years 1959-1967 inclusive,
which is the most recent period for which
data are available (8); and (d) there is
little or no evidence of seasonal variation
in the incidence of the disease in the U.S.
(9) or of clustering of cases (10).
Leukemia death rates would need to be
monitored on a national as opposed to a re-
gional basis, not only to have enough num-
bers to examine trends by type of leukemia,
age, race, and sex but also because the popu-
lation at risk is easier to estimate for the
U.S. as a whole than it is for regions which
tend to have ill-defined patterns of migra-
tion. It would, of course, be much more
desirable to monitor leukemia incidence
rates (number of new cases arising in a
given time interval) rather than death
rates. However, until national registries of
cancer cases in this country are developed,
it will be necessary to rely upon death rec-
ords. Moreover, advantage can be taken of
the circumstance that for acute leukemia, in
adults especially, there is a relatively short
period between time of clinical onset and
death; for example, the median survival
time for adults over 45 was only increased
from one month to two months in the per-
iod from 1940 to 1962 (11). Hence, for
acute leukemia in older adults, death rates
are expected to parallel incidence rates quite
closely, at least until better survivorship is
achieved.
I would like to cite an example which il-
lustrates the power of death record studies
to identify associations between leukemia
mortality and environmental factors. An as-
sociation between farming and leukemia in
this country was first detected by Gural-
nick (12), who analyzed cause of death in
relation to occupation among U.S. males (age
20 to 64) for the year 1950. She observed
a mortality rate from leukemia which was
significantly higher in white agricultural
workers than it was in the general male
population even though mortality rates from
all categories of cancers combined were
significantly lower in the agricultural group.
Unfortunately, studies of cause of death in
relation to occupation have not been carried
out at a national level in the years since
1950. However, death record studies made
in the State of California for the years
1959-1961 showed a similar association be-
tween farm residence and leukemia mortal-
ity (13). More recently, Milham (14) not
only confirmed the association with farm
occupation in a study of death records for
the States of Washington (for the years
1950-1967) and Oregon (1950-1964) but
had sufficient numbers to analyze the as-
sociation in relation to six types of farm-
ing. By a matched control technique he
found that the leukemia risk was elevated
in each of the six types of farming with
the highest risk occurring in poultry farm-
ers.
A specificity of association to type of leu-
kemia was also noted by Milham (14), who
found that lymphatic leukemia tended to be
elevated proportionately more than the mye-
loid type when farm workers were compared
to a matched control group. By contrast, in
persons exposed to ionizing radiation the
myeloid types are elevated proportionately
more than the lymphatic ones; indeed, chro-
nic lymphatic leukemia appears not to be
readily inducible by ionizing radiation if it
is inducible at all (1). Milham (14) sug-
gests that an animal tumor virus may be
the agent responsible for the increased risk
of leukemia in farm workers.
For our purposes there are a number of
points of interest in this example of an as-
sociation between occupation and leukemia
mortality. (a) The original association was
identified solely by the use of death record
data correlated with census estimates of
the number of farm workers. (b) Only a na-
tional study can yield enough cases of leu-
kemia within the space of one year or less
to detect the rather weak associations which
are present when leukemia mortality is re-
lated to all types of farming combined. (c)
The existence of an association that is spe-
cific to a certain type or types of leukemia
can be expected to increase greatly the re-
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gram. (d) Although death record studies
can identify a risk, further epidemiological
studies will generally be needed to identify
the nature of the factor(s) involved.
A program of prompt monitoring and
analysis of leukemia deaths would require
careful planning and the cooperation of a
number of agencies. One might envisage the
initial goal to be the detection of any signif-
icant changes in death rates within one or
two years after those changes had occurred.
The ultimate goal might be to reduce this
time interval to a few months. Death rec-
ords with mention of leukemia would be
singled out for special processing. Such a
selection procedure would avoid waiting un-
til all death records had been coded to un-
derlying cause. Coding to cause by the rules
of the Eighth International Revision,
adopted in 1968, should insure adequate
breakdown of leukemia deaths by type.
Prior to 1968, deaths ascribed to acute lym-
phatic or acute myeloid leukemia, two of
the most useful categories for present pur-
poses, were "lost" to analysis simply as the
result of an artifact of grouping imposed by
the coding rules then in effect. It would be
highly desirable to code from the records
data on a number of relevant items which
are not regularly coded in the case of all
records; namely, such items as, for ex-
ample, occupation and industry, interval be-
tween onset and death, and whether resi-
dence is on a farm.
To give some idea of the number of rec-
ords that would be available for analysis,
there were 14,375 deaths certified to leu-
kemia in the U.S. in the year 1968, the most
recent year for which data have been pub-
lished (15). Under acute leukemia there were
7494 deaths, the bulk of which fell into three
categories: 1842 acute lymphatic; 3126 acute
myeloid; and 1847 acute deaths without men-
tion of cell type.
It would be envisaged that the basic data
would be analyzed for time trends in age-
specific death rates for each major type of
leukemia. Burbank (8) has analyzed such
trends for leukemia (and other cancers) in
the U.S. for the nine-year period, 1959-1967.
He has paid particular attention to the prob-
lem of determining the statistical signifi-
cance of observed trends and his procedures
are model ones for future investigations.
If occupation is coded from the records,
a single year should provide sufficient data,
judging by the 1950 study (12) already
cited, to determine the present status of the
association of farming with leukemia. The
primary purpose of the proposed monitoring
program would still be to detect any sud-
den changes in leukemia mortality rates that
might be due to environmental agents. Such
a program would also have the resolving
power of detecting annual trends in already
recognized associations as well as identify-
ing new associations that may already
have existed but have gone unrecognized
because of lack of sufficient data.
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Discussion
Dr. C. Langley (Univ. of Wisconsin): How many
state Health Departments keep monthly records on
leukemia?
Dr. Lewis: All states keep monthly death records.
Dr. H. E. Sutton (Univ. of Texas at Austin):
This discussion on leukemia brings up a point which
you alluded to, that is the enormously increased risk
from early embryonic radiation. I'm not sure what
the current risk figure is; in any event it raises the
possibility that perhaps we are most susceptible to
mutation before our repair systems are fully de-
veloped and perhaps the additional mutation after
birth is after all rather trivial. I think this is more
pertinent to leukemia. With most test systems that
are used, one starts with an adult male and subjects
him to radiation or other treatment; perhaps if one
used the experimentally more complicated method of
going back and treating him while he's still an
embryo we might find that in fact the mutational
risk is enormously higher.
Dr. Lewis: You're quite right that there is a
relatively high risk but only for 10 years. There is
a curious development first pointed out some years
ago by Doll that older persons become relatively
sensitive to radiation, as the fetus does. What could
easily be involved is the phenomenon that initially
there are relatively few cells that could be inducible
as far as leukemia is concerned, but with aging, be-
cause of the breakdown of systems of various kinds
the effective number of cells susceptible to induc-
tion increases exponentially.
Dr. Sutton: I saw recently a report that among
young children where leukemia is induced there
appeared to be two populations, one sensitive and one
resistant.
Dr. Lewis: There are studies by Gibson and
others in which it was noted that pathological fac-
tors were interacting with radiological factors. I
don't think it has yet been proven that you have to
have an association of radiation and another specific
variable.
Dr. Sutton: Couldn't one of the other variables
be the genetic background in the person?
Dr. Lewis: Oh, by all means it could be. I guess
you're thinking of Fanconi's anemia.
Dr. Sutton: No, but that's a nice example.
Dr. R. F. Kimball (ORNL): To return to Dr.
Sutton's remarks that repair systems, by that I'm
taking it to mean DNA repair, might be ineffective
in early embryos. I don't know if there is such
evidence. Immunological systems are something else
again, but I was not aware that there was any
evidence at all that DNA repair systems had any
kind of periods in the development.
Dr. Sutton: I don't know of any evidence, but
there are many other enzymes that simply do not
become fully functional on day one.
Dr. R. L. Capizzi (Yale Univ.): A comment and
a question. Perhaps chronic lymphatic leukemia
(CLL) ought not to be dismissed, because it might
be a useful disease to follow. The division into B
cells and T cells, i.e., bone marrow or bursa-derived
and thymus-derived lymphocytes, is a useful way of
dividing the CLL population. There have been some
patients who exhibit pure B cell leukemias and some
that exhibit pure T cell leukemia. The other inter-
esting feature about this disease is that some of the
CLL patients will secrete specific immunoglobulins,
the genetics of which have been worked out nicely
and which may indicate a specific clonal origin of the
leukemia. The only problem in an epidemiological
sense might be that, since this disease appears in an
older population, we may be dealing with a very long
latency period. However, a good epidemiologist has
lots of questions and lots of ways of evoking
answers and recall in the patients that are inter-
viewed. I think it might be very useful disease to
include.
The question is: Lots of studies have been done on
leukemia clusters, in particular those sponsored by
the CBC in Atlanta; infectious, chemical, or radia-
tion exposures in a community or family were in-
vestigated. Do you have any comments on that?
Dr. Lewis: First on the CLL: it seems to me
this reinforces the point I was trying to make, that
you need that as a control group, even if it isn't
radiation-induced. I do want to stress that you
wouldn't restrict yourself to the radiation type you
would want to include that very type. I gather
originally it was thought that CLL's were nonclonal
and now all of them are turning out to be clonal.
Dr. Capizzi: The methodology is being developed
for the recognition.
Dr. Lewis: With respect to your question about the
clusters, what I've read on this is that it always
seems as if the most careful epidemiological investi-
gation indicates that it is not a true cluster but a
statistical cluster, i.e., one that you would expect on
a chance basis.
Dr. Capizzi: There are two other diseases that
may be interesting in this category. One is parox-
ysmal nocturnal hemoglobinurea (the Machiafaba-
Michelli syndrome), which appears in many patients
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urine in an intermittent fashion, in paroxysms,
during the night. This disease frequently is recog-
nized after exposure to a chemical agent-most of
the agents that will suppress bone marrow func-
tion-like benzene or organic solvents. Some of these
patients will then go into an aplastic phase and some
of them will then also develop a myologeneous
leukemia, perhaps related to the initial exposure. As
far as I know, there is not a lot of epidemiological
study on this disease. The other disease which
terminates frequently in leukemia is polycythemia
vera, and we don't know what causes that. Initially it
is an increase in red cells, but there is an increase
also in the white cells and platelets. Patients develop
thrombotic problems initially but frequently termi-
nate in leukemia, regardless of whether or not
they've been treated with '3P, which used to be a
standard form of therapy.
Dr. S. S. Epstein (Case Western Reserve): I'd
just like to say first of all how much I enjoyed your
brilliant, stimulating presentation. I'm just wonder-
ing about this idea of yours of monitoring on a state
level. On the basis of the figures you gave, say, 1000
deaths from leukemia per month in this country,
there are roughly 20 leukemia deaths per month per
state, of which half are myeloid, so you have 10
myeloid deaths per state per month. A 10'S increase
would be one death per state. Do you think this is of
sufficient sensitivity to merit the kind of procedures
you are recommending?
Dr. Lewis: I was thinking of it in terms of an
increase of approximately 60 acute deaths per month
in the entire U.S.
Dr. C. Ramel (Univ. of Stockholm): Another
class which has a rather short lag period after ex-
posure and which may open up some possibilities
is nerve cancers in children, which I understand in
Sweden has had a significant increase in the last
decade.
Dr. Epstein: There was a paper by Jack Schubert
of which I'm sure many of you are aware, reporting
almost a tripling of the incidence of CNS tumors in
children in Sweden from the years 1948 to about
1969. Many of us were fascinated by these data and
presented it to the NCI for computer analysis. The
incidence of CNS tumors was increased in children
under the ages of 7 or 8. There was no excess of
CNS tumors in people over that age. The curve has
been found to be exactly flat for the American data.
There is absolutely no increase in this country what-
soever. The reason why so many of us were in-
terested in this is because in recent years or so there
have been numerous reports on transplacental car-
cinogenesis, particularly to N-nitroso compounds. In
a wide range of rodents that were given N-nitroso
compounds, particularly in the latter part of preg-
nancy, there was a very high incidence of CNS
tumors in the offspring. The question is then wheth-
er increase in incidence of tumors in Sweden reflects
prenatal exposure to N-nitroso compounds, and, if
indeed this is the case in Sweden, why these data
are not reflected in the American series.
Dr. G. Wolff (NCTR): I want to come back to
the question that Dr. Kimball raised regarding the
assumption of Dr. Sutton's statement about lack of
repair leading to increased mutagenesis in embryos.
To go one step beyond that, I think we should be
cautious in accepting the notion that you do get
-increased mutagenesis when there is lack of repair.
It might have heuristic value to consider this but
we should keep in mind that there are cases where
this may not be so. We've done experiments in which
we find no excision repair in plants (Bill Hanawalt,
Jim Trosko) and yet these plant cells don't seem
to be throwing mutants all the time. And yesterday
Dr. DeSerres told us about his work in Neurospora
in which he had six repairless mutants and while
two of them did indeed show an increase in muta-
tions, some of them were mutation-resistant, and so
the basic hypothesis might not be correct.
Dr. Cumming (ORNL): I want to get back to
Dr. Sutton's initial comment on the increased sensi-
tivity in utero and refer to the specific locus data.
Paul Selby just completed a series of studies with
Bill Russell on age-dependent differences in specific
locus mutation rate. The mutation rates induced by
x-rays on the first day postnatally, (first 9 hr after
birth) are significantly below mutation rates for
adults and not significantly different from the
meagre in utero data. It appears that the very young
organisms are less sensitive rather than more sensi-
tive to mutation induction by x-rays, and the shift
from the low mutation-induction rate to the high one
comes within the first week of life (postnatal) in
mice. So to assume that sensitivity to a mutagen is
going to parallel what we will find in leukemia is
a big jump. I think we have to really keep in mind
that we're really concerned with mutation induction.
Dr. S. Abrahamson (Univ. of Wisconsin): That's
the experiment in which newborn females were ir-
radiated. They had 1/6 the mutation rate, and
newborn males irradiated had 1/2 the mutation rate.
Dr. Cumming: That's right-in both cases, the
mutation rates were significantly below the adult
rate.
Dr. Abrahamson: But were there in utero ex-
periments done by Shelby?
Dr. Cumming: Shelby didn't do them, there
have been limited in utero experiments done by
others, and those data do not differ statistically
from Shelby's results for day. They're lower than
the results from day one.
Dr. Lewis: I might say that the maternal and pa-
ternal exposures prior to conception were looked at
carefully in a number of studies and don't show
really significant associations in a consistent way.
There is something peculiar about the mongol
result, by the way. If the Polani group is correct, the
risk of mongolism is increased by an exposure that
December 1973 189is only 1-2 rad. One would not expect from among
the existing estimates that there could be such a high
rate of nondisjunction. What the explanation is, I
have no idea. I suspect it might be related to the
presence of some highly sensitive cells that are
usually killed by 100 rad, but often affected by 1
rad. Now that's not mutation, of course, but rather
nondisjunction.
Dr. Abrahamson: The Uchida data that you re-
ferred to earlier also showed this increase, but the
increase was only in that group of females who were
over the age of 38 at the time of irradiation.
Dr. Lewis: That was a very small sample. I
think anything could come from that small sample.
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